Skip to main content

Advertisement

SpringerLink
Log in

Langerhans cells in vaccinia virus infection in mouse skin

  • Brief Report
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Langerhans cells function as potent antigen-presenting cells in the epidermis. They were shown to play an essential role in the mechanisms of defense of the skin against viral infections. In the present study, the response of Langerhans cells to infection of the skin with vaccinia virus was investigated. Decrease in Langerhans cell density in the skin was accompanied by an increase in the pathogenicity of the WR and Noguchi but not of the Lister strain of vaccinia virus. Langerhans cell density was shown to increase rapidly at the site of inoculation with the two pathogenic strains of vaccinia virus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Baker KW, Habowsky JEJ (1983) EDTA separation and ATPase Langerhans cell staining in the mouse epidermis. J Invest Dermatol 80: 104–107

    Google Scholar 

  2. Balfour BM, Drexhage HA, Kamperdijk EWA, Hoefsmit EChM (1981) Antigenpresenting cells, including Langerhans cells, veiled cells and interdigitating cells. Ciba Found Symp 84: 281–301

    Google Scholar 

  3. Becker Y (1987) The need for characterization of pathogenicity genes of recombinant DNA viruses used as human vaccines. Virus Genes 1: 117–120

    Google Scholar 

  4. Belsito DV, Sanchez MR, Baer RL, Valentine F, Thorbecke GJ (1984) Reduced Langerhans cell Ia antigens and ATPase activity in patients with the acquired immunodeficiency syndrome. N Engl J Med 310: 1279–1282

    Google Scholar 

  5. Ben-Ishai Z, Heller E, Goldblum N, Becker Y (1969) Rifampicin and poxvirus replication. Nature 224: 29–34

    Google Scholar 

  6. Bergstresser PR, Juarez DV (1984) Detection by immunochemical technique of cell surface markers on epidermal Langerhans cells. Methods Enzymol 108: 683–691 [Di Sabato G, Langone JJ, Vunakis HV (eds) Immunochemical techniques]

    Google Scholar 

  7. Braathen LR, Berle E, Mobech-Hansen U, Thorsby E (1980) Activation of human T lymphocytes to herpes simplex virus. Acta Derm Venerol (Stockh) 60: 381–387

    Google Scholar 

  8. Brathen LR, Kaaman T (1983) Human epidermal Langerhans cells induce cellular immune response to trichophytin in dermatophytosis. Br J Dermatol 109: 295–300

    Google Scholar 

  9. Buller RML, Smith GL, Cremer K, Notkins AL, Moss B (1985) Decrease virulence of recombinant vacinia virus expression vectors is associated with a thymidine kinasenegative phenotype. Nature 317: 813–815

    Google Scholar 

  10. Chakrabati S, Robert-Gurrof M, Wong-Staal F, Gallo RC, Moss B (1986) Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature 320: 535–537

    Google Scholar 

  11. Dompmartin A, Healy AT, Nacy CA, Hauser C, Meltzer MS (1988) Leishmania major infects and replicates within murine epidermal Langerhans cells. J Invest Dermatol 91: 404

    Google Scholar 

  12. Dreno B, Milpeid B, Bignon JB, Stalder JF, Litoux P (1988) Prognostic value of Langerhans cells in the epidermis of HIV patients. Br J Dermatol 118: 481–486

    Google Scholar 

  13. Garcia-Olivares E, Carreras B, Gallardo JM (1988) Presence of Langerhans cells in the cornea of Klebsiella keratoconjunctivitis mice. Invest Ophthalmol Vis Sci 29: 108–111

    Google Scholar 

  14. Hayashi Y, Aurelian L (1986) Immunity to herpes simplex type 2: viral antigen-presenting capacity of epidermal cells and its impairment by ultraviolet irradiation. J Immunol 136: 1087–1092

    Google Scholar 

  15. Knop J, Enk A, Heremans H (1988) Release of interferon-γ by epidermal Langerhans cells. J Invest Dermatol 90: 246

    Google Scholar 

  16. Macatonia SE, Knight SE, Edwards AJ (1987) Griffiths S, Fryer F, Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 166: 1654–1667

    Google Scholar 

  17. Mallon RV, Domber EA, Holowczak JA (1985) Vaccinia virus proteins on the plasma membrane of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells. Virology 145: 1–23

    Google Scholar 

  18. Nagao S, Inaba S (1976) Langerhans cells at the site of vaccinia virus inoculation. Arch Dermatol Res 256: 23–31

    Google Scholar 

  19. Otani T, Mori R (1987) The effects of ultralviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection. Arch Virol 96: 1–15

    Google Scholar 

  20. Paoletti E, Lipinskas BR, Samsonoff C, Mercer S, Panicalli D (1984) Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus expressing the hepatitis B virus surface andtigen and the herpes simplex glycoprotein D. Proc Natl Acad Sci USA 82: 193–197

    Google Scholar 

  21. Rappersberger K, Gartner S, Schenk P, Stingl G, Groh V, Tschaler E, Mann DL, Wolff K, Konrad K, Popovic M (1988) Langerhans cells are an actual site of HIV-1 replication. Intervirology 29: 185–194

    Google Scholar 

  22. Redfield RR, Wright DR, James WD, Jones TS, Brown C, Burke DS (1987) Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 316: 673–676

    Google Scholar 

  23. Rowden G, Lewis MG, Sullivan AK (1977) Ia antigen expression on human epidermal Langerhans cells. Nature 268: 247

    Google Scholar 

  24. Sprecher E, Becker Y (1986) Skin Langerhans cells play an essential role in the defense against HSV-1 infection Arch Virol 91: 341–349

    Google Scholar 

  25. Sprecher E, Becker Y (1987) Herpes simplex virus type 1 pathogenicity in footpad and ear skin of mice depends on Langerhans cell density, mouse genetics and virus strain. J Virol 61: 2515–2522

    Google Scholar 

  26. Sprecher E, Becker Y (1988) Role of epidermal Langerhans cells in viral infections. ArchVirol 103: 1–14

    Google Scholar 

  27. Tschachler E, Groh V, Popovic M, Mann DL, Konrad K, Safai B, Eron L, di Marzo Veronese F, Wolff K, Stingl G (1987) Epidermal Langerhans cells—a target for HTLV-III/LAV infection. J Invest Dermatol 88: 233

    Google Scholar 

  28. Wong GHW, Goeddel DV (1986) Tumour necrosis factor α and β inhibit virus replication and synergize with interferons. Nature 323: 819–822

    Google Scholar 

  29. Yasumoto S, Hayashi Y, Aurelian L (1987) Immunity to herpes simplex virus type 2: Suppression of virus-induced immune responses in ultraviolet B-irradiated mice. J Immunol 139: 2788–2793

    Google Scholar 

  30. Yasumoto S, Okabe N, Mori R (1986) Role of epidermal Langerhans cells in resistance to HSV infection. Arch Virol 90: 261–271

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Virology, Faculty of Medicine, Hebrew University, Jerusalem, Israel

    Y. Becker & E. Sprecher

Authors
  1. Y. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Sprecher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Becker, Y., Sprecher, E. Langerhans cells in vaccinia virus infection in mouse skin. Archives of Virology 107, 307–313 (1989). https://doi.org/10.1007/BF01317926

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01317926

Keywords

Search

Navigation